125 related articles for article (PubMed ID: 6932563)
1. Delayed allergic reactions following intramuscular L-asparaginase.
Spiegel RJ; Echelberger CK; Poplack DG
Med Pediatr Oncol; 1980; 8(2):123-5. PubMed ID: 6932563
[TBL] [Abstract][Full Text] [Related]
2. The Incidence of Hypersensitivity Reactions to Pegylated Asparaginase in Children With Acute Lymphoblastic Leukemia: A City-wide Experience.
Alrazzak M; Beaupin LK; Kinyoun P; Barth M
J Pediatr Hematol Oncol; 2016 Jan; 38(1):e16-20. PubMed ID: 26558809
[TBL] [Abstract][Full Text] [Related]
3. Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemia.
Steuber CP; Levy GJ; Nix WL; Shepherd DA; Starling KA; Fernbach DJ
Med Pediatr Oncol; 1978; 5(1):33-8. PubMed ID: 311413
[TBL] [Abstract][Full Text] [Related]
4. Comparison of allergic reactions to pegasparaginase given intravenously versus intramuscularly.
Pidaparti M; Bostrom B
Pediatr Blood Cancer; 2012 Sep; 59(3):436-9. PubMed ID: 22021170
[TBL] [Abstract][Full Text] [Related]
5. Delayed-type hypersensitivity in response to L-asparaginase in a case of acute lymphoblastic leukemia.
Narazaki H; Kaizu K; Miyatake C; Koizumi S; Asano T; Fujino O
J Nippon Med Sch; 2012; 79(6):489-93. PubMed ID: 23291850
[TBL] [Abstract][Full Text] [Related]
6. [Sensitization to L-asparaginase during the treatment of lymphoblastic leukosis].
Popović K; Ilić V; Spevak L
Srp Arh Celok Lek; 1972 Mar; 100(3):387-90. PubMed ID: 4505679
[No Abstract] [Full Text] [Related]
7. [Allergic meningitis due to asparaginase sensitivity during acute lymphoblastic leukemia].
Goudemand M; Delmas-Marsalet Y; Bauters F
Nouv Presse Med; 1972 Jan; 1(4):268. PubMed ID: 4258682
[No Abstract] [Full Text] [Related]
8. L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone.
Smithson WA; Gilchrist GS; Burgert EO
Med Pediatr Oncol; 1979; 6(2):163-70. PubMed ID: 287856
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia.
Nesbit M; Chard R; Evans A; Karon M; Hammond GD
Am J Pediatr Hematol Oncol; 1979; 1(1):9-13. PubMed ID: 295576
[TBL] [Abstract][Full Text] [Related]
10. Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase.
Billett AL; Carls A; Gelber RD; Sallan SE
Cancer; 1992 Jul; 70(1):201-6. PubMed ID: 1606543
[TBL] [Abstract][Full Text] [Related]
11. Anaphylaxis to L-asparaginase during treatment for acute lymphoblastic leukemia in children--evidence of a complement-mediated mechanism.
Fabry U; Körholz D; Jürgens H; Göbel U; Wahn V
Pediatr Res; 1985 Apr; 19(4):400-8. PubMed ID: 3858789
[TBL] [Abstract][Full Text] [Related]
12. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK;
Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987
[TBL] [Abstract][Full Text] [Related]
13. L-asparaginase reinduction and maintenance therapy in previously treated acute lymphocytic leukemia.
Sieger L; Higgins G; Ortega J; Shore N; Williams K
Med Pediatr Oncol; 1976; 2(3):327-32. PubMed ID: 1068340
[TBL] [Abstract][Full Text] [Related]
14. Comparison of anaphylactic reactions to asparaginase derived from Escherichia coli and from Erwinia cultures.
Dellinger CT; Miale TD
Cancer; 1976 Oct; 38(4):1843-6. PubMed ID: 791476
[TBL] [Abstract][Full Text] [Related]
15. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group.
Nesbit ME; Ertel I; Hammond GD
Cancer Treat Rep; 1981; 65 Suppl 4():101-7. PubMed ID: 7049373
[TBL] [Abstract][Full Text] [Related]
16. [L-Asparaginase in the treatment of acute leukemia].
Mathé G; Amiel JL; Clarysse A; Hayat M; Schwarzenberg L; Schneider M
Sem Hop; 1970 Apr; 46(17):1135-40. PubMed ID: 4315231
[No Abstract] [Full Text] [Related]
17. Immunological aspects of L-asparaginase treatment in children with lymphoproliferative disease.
Zajaczkowski J; Pituch A; Legutko L; Pajak E
Helv Paediatr Acta; 1976 Jan; 30(4-5):441-6. PubMed ID: 1060605
[TBL] [Abstract][Full Text] [Related]
18. [Immunization against L-asparaginase. Demonstration and characteristics of antibodies. Clinical value].
Marsalet YD; Lambert G; Hornez JP; Bauters F; Goudemand M
Nouv Presse Med; 1973 Jun; 2(23):1575-8. PubMed ID: 4197351
[No Abstract] [Full Text] [Related]
19. Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia.
Soyer OU; Aytac S; Tuncer A; Cetin M; Yetgin S; Sekerel BE
J Allergy Clin Immunol; 2009 Apr; 123(4):895-9. PubMed ID: 19081614
[TBL] [Abstract][Full Text] [Related]
20. E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children.
Tallal L; Tan C; Oettgen H; Wollner N; McCarthy M; Helson L; Burchenal J; Karnofsky D; Murphy ML
Cancer; 1970 Feb; 25(2):306-20. PubMed ID: 4905155
[No Abstract] [Full Text] [Related]
[Next] [New Search]